צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים Hologic (HOLX)

Hologic, Inc. (HOLX) dominates the 3D mammography niche, benefiting from the global expansion of services. High equipment quality is ensured by robotic assembly with machine vision control. The history of quarterly EPS changes confirms the resilience of the model: -8.20 shows the level of this metric. The business relies on a powerful consumables lever, which generates colossal margins with minimal production costs.

Professional managers select assets based on the dynamics of fundamental metrics. This indicator measures the percentage change in net income per share, eliminating time gaps between quarterly reports. For Hologic, Inc. (HOLX), this confirms the effectiveness of reinvesting pandemic windfall profits into strategic M&A deals. A steady climb in recorded quarterly EPS growth signals the expansion of the core business. However, peak values warrant caution due to correction risks.